Addus HomeCare Co. (NASDAQ:ADUS) Receives $131.63 Average Price Target from Analysts

Addus HomeCare Co. (NASDAQ:ADUS) has earned a consensus rating of “Moderate Buy” from the nine research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, seven have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $131.63.

Several analysts have recently commented on ADUS shares. TD Cowen lifted their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Stephens lifted their target price on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. KeyCorp assumed coverage on Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective for the company. Macquarie restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $118.27 on Tuesday. The stock’s fifty day moving average is $128.82 and its two-hundred day moving average is $122.73. The firm has a market capitalization of $2.14 billion, a P/E ratio of 27.06, a price-to-earnings-growth ratio of 2.09 and a beta of 1.04. Addus HomeCare has a fifty-two week low of $85.43 and a fifty-two week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same quarter in the previous year, the company posted $1.03 EPS. The company’s revenue was up 7.1% compared to the same quarter last year. As a group, sell-side analysts forecast that Addus HomeCare will post 4.58 EPS for the current year.

Insider Activity

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total value of $65,015.00. Following the sale, the director now owns 3,866 shares of the company’s stock, valued at $502,695.98. This trade represents a 11.45 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This represents a 75.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in ADUS. UMB Bank n.a. raised its holdings in shares of Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after purchasing an additional 88 shares in the last quarter. Quarry LP purchased a new stake in Addus HomeCare during the 3rd quarter worth about $28,000. Quest Partners LLC acquired a new position in shares of Addus HomeCare during the 2nd quarter worth about $31,000. EntryPoint Capital LLC purchased a new position in shares of Addus HomeCare in the 1st quarter valued at about $44,000. Finally, Innealta Capital LLC acquired a new stake in shares of Addus HomeCare during the 2nd quarter worth about $44,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.